The nervous system as a critical regulator of immune responses underlying allergy

Current Pharmaceutical Design

Volumn 18, Issue 16, 2012, Pages 2290-2304

  Forsythe, Paul ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Brain; Inflammation; Neuropeptides; Sympathetic nervous system; Vagus

Indexed keywords

ACETYLCHOLINE; ALLERGEN; ANTIGEN; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCITONIN GENE RELATED PEPTIDE; CHLORIDE CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; CYTOKINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; INTERLEUKIN 33; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROTENSIN; NEUROTRANSMITTER; NORADRENALIN; OVALBUMIN; SEROTONIN 3 ANTAGONIST; SUBSTANCE P; T LYMPHOCYTE RECEPTOR; VANILLOID RECEPTOR 1; VASCULOTROPIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADRENERGIC SYSTEM; ALLERGY; AMYGDALOID NUCLEUS; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANXIETY; ARTICLE; ASTHMA; ATOPY; AUTOIMMUNITY; AVOIDANCE BEHAVIOR; B LYMPHOCYTE; BEHAVIOR; BRAIN; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CYTOKINE PRODUCTION; DENDRITIC CELL; DIABETES MELLITUS; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; INFLAMMATION; MAST CELL; NERVE; NERVE CELL; NERVOUS SYSTEM; NEUROIMMUNOLOGY; NEUROMODULATION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PANCREAS; PARASYMPATHETIC NERVE; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SENSITIZATION; SOLITARY TRACT NUCLEUS; STRESS; T LYMPHOCYTE; VAGUS NERVE;

BRAIN; CELL COMMUNICATION; HUMANS; HYPERSENSITIVITY; MAST CELLS; NEURONS; RECEPTORS, IMMUNOLOGIC; SYMPATHETIC NERVOUS SYSTEM;

EID: 84860111262     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212800165951     Document Type: Article

References (232)

1. Sternberg EM. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 2006; 6: 318-328.
2. Kin NW, Sanders VM. It takes nerve to tell T and B cells what to do. J Leukoc Biol 2006; 79: 1093-1104.
3. Wrona D. Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. J Neuroimmunol 2006; 172: 38-58.
4. Romano TA, Felten SY, Olschowka JA, Felten DL. Noradrenergic and peptidergic innervation of lymphoid organs in the beluga, Delphinapterus leucas: an anatomical link between the nervous and immune systems. J Morphol 1994; 221: 243-259.
5. Felten DL, Felten SY, Bellinger DL, Lorton D. Noradrenergic and peptidergic innervation of secondary lymphoid organs: role in experimental rheumatoid arthritis. Eur J Clin Invest 1992; 22 Suppl 1: 37-41.
6. Bienenstock J, Denburg J, Scicchitano R, Stead R, Perdue M, Stanisz A. Role of neuropeptides, nerves and mast cells in intestinal immunity and physiology. Monogr Allergy 1988; 24: 134-143.
7. Tracey KJ. Physiology and immunology of the cholinergic anti-inflammatory pathway. J Clin Invest 2007; 117: 289-296.
8. Sternberg EM. Neuroendocrine regulation of autoimmune/ inflammatory disease. J Endocrinol 2001; 169: 429-435.
9. Tracey KJ. The inflammatory reflex. Nature 2002; 420: 853-859.
10. Shepherd AJ, Downing JE, Miyan JA. Without nerves, immunology remains incomplete -in vivo veritas. Immunology 2005; 116: 145-163.
11. Berczi I, Chalmers IM, Nagy E, Warrington RJ. The immune effects of neuropeptides. Baillieres Clin Rheumatol 1996; 10: 227-257.
12. Civantos Calzada B, Aleixandre de Artinano A. Alphaadrenoceptor subtypes. Pharmacol Res 2001; 44: 195-208.
13. Molenaar P. The 'state' of beta-adrenoceptors. Br J Pharmacol 2003; 140: 1-2.
14. Burnstock G. Mechanisms of interaction of peptide and nonpeptide vascular neurotransmitter systems. J Cardiovasc Pharmacol 1987; 10 Suppl 12: S74-81.
15. Panuncio AL, de La Pena S, Gualco G, Reissenweber N. Adrenergic innervation in reactive human lymph nodes. J Anat 1999; 194: 143-146.
16. Maestroni GJ. Adrenergic modulation of dendritic cells function: relevance for the immune homeostasis. Curr Neurovasc Res 2005; 2: 169-173.
17. Yanagawa Y, Matsumoto M, Togashi H. Adrenoceptor-mediated enhancement of interleukin-33 production by dendritic cells. Brain Behav Immun 2011
18. Kim BJ, Jones HP. Epinephrine-primed murine bone marrowderived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-gamma by CD4+ T cells. Brain Behav Immun 2010; 24: 1126-1136.
19. Yanagawa Y, Matsumoto M, Togashi H. Enhanced dendritic cell antigen uptake via alpha2 adrenoceptor-mediated PI3K activation following brief exposure to noradrenaline. J Immunol 2010; 185: 5762-5768.
20. Wheway J, Mackay CR, Newton RA, et al. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med 2005; 202: 1527-1538.
21. Alaniz RC, Thomas SA, Perez-Melgosa M, et al. Dopamine betahydroxylase deficiency impairs cellular immunity. Proc Natl Acad Sci USA 1999; 96: 2274-2278.
22. Swanson MA, Lee WT, Sanders VM. IFN-gamma production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine. J Immunol 2001; 166: 232-40.
23. Ramer-Quinn DS, Swanson MA, Lee WT, Sanders VM. Cytokine production by naive and primary effector CD4+ T cells exposed to norepinephrine. Brain Behav Immun 2000; 14: 239-255.
24. Sanders VM, Straub RH. Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav Immun 2002; 16: 290-332.
25. Ramer-Quinn DS, Baker RA, Sanders VM. Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J Immunol 1997; 159: 4857-4867.
26. Takahashi H, Kobayashi M, Tsuda Y, Herndon DN, Suzuki F. Contribution of the sympathetic nervous system on the burnassociated impairment of CCL3 production. Cytokine 2005; 29: 208-214.
27. Takahashi H, Tsuda Y, Kobayashi M, Herndon DN, Suzuki F. Increased norepinephrine production associated with burn injuries results in CCL2 production and type 2 T cell generation. Burns 2004; 30: 317-321.
28. Sanders VM. The role of adrenoceptor-mediated signals in the modulation of lymphocyte function. Adv Neuroimmunol 1995; 5: 283-298.
29. Sanders VM, Baker RA, Ramer-Quinn DS, Kasprowicz DJ, Fuchs BA, Street NE. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol 1997; 158: 4200-4210.
30. Pongratz G, McAlees JW, Conrad DH, Erbe RS, Haas KM, Sanders VM. The level of IgE produced by a B cell is regulated by norepinephrine in a p38 MAPK- and CD23-dependent manner. J Immunol 2006; 177: 2926-2938.
31. Faisy C, Pinto FM, Blouquit-Laye S, et al. beta2-Agonist modulates epithelial gene expression involved in the T- and B-cell chemotaxis and induces airway sensitization in human isolated bronchi. Pharmacol Res 2010; 61: 121-128.
32. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996; 272: 50-53.
33. Coqueret O, Dugas B, Mencia-Huerta JM, Braquet P. Regulation of IgE production from human mononuclear cells by beta 2- adrenoceptor agonists. Clin Exp Allergy 1995; 25: 304-311.
34. Dhabhar FS, McEwen BS. Stress-induced enhancement of antigenspecific cell-mediated immunity. J Immunol 1996; 156: 2608-2615.
35. Dhabhar FS, McEwen BS. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci USA 1999; 96: 1059-1064.
36. Dhabhar FS, Satoskar AR, Bluethmann H, David JR, McEwen BS. Stress-induced enhancement of skin immune function: A role for gamma interferon. Proc Natl Acad Sci USA 2000; 97: 2846-2851.
37. Krantz DS, Sheps DS, Carney RM, Natelson BH. Effects of mental stress in patients with coronary artery disease: evidence and clinical implications. Jama 2000; 283: 1800-1802.
38. Vettore MV, Leao AT, Monteiro Da Silva AM, Quintanilha RS, Lamarca GA. The relationship of stress and anxiety with chronic periodontitis. J Clin Periodontol 2003; 30: 394-402.
39. Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 2005; 54: 1481-91.
40. Joachim RA, Noga O, Sagach V, et al. Correlation between immune and neuronal parameters and stress perception in allergic asthmatics. Clin Exp Allergy 2008; 38: 283-290.
41. Kullowatz A, Rosenfield D, Dahme B, Magnussen H, Kanniess F, Ritz T. Stress effects on lung function in asthma are mediated by changes in airway inflammation. Psychosom Med 2008; 70: 468-475.
42. Arck P, Paus R. From the brain-skin connection: the neuroendocrine- immune misalliance of stress and itch. Neuroimmunomodulation 2006; 13: 347-356.
43. Kimata H. Enhancement of allergic skin wheal responses and in vitro allergen-specific IgE production by computer-induced stressin patients with atopic dermatitis. Brain Behav Immun 2003; 17: 134-138.
44. Bierhaus A, Wolf J, Andrassy M, et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA 2003; 100: 1920-1925.
45. Miller GE, Chen E. Life stress and diminished expression of genes encoding glucocorticoid receptor and beta2-adrenergic receptor in children with asthma. Proc Natl Acad Sci USA 2006; 103: 5496-5501.
46. Baluk P. Neurogenic inflammation in skin and airways. J Investig Dermatol Symp Proc 1997; 2: 76-81.
47. Brain SD. Sensory neuropeptides: their role in inflammation and wound healing. Immunopharmacology 1997; 37: 133-152.
48. O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol 2004; 201: 167-180.
49. Sann H, Dux M, Schemann M, Jancso G. Neurogenic inflammation in the gastrointestinal tract of the rat. Neurosci Lett 1996; 219: 147-150.
50. Koon HW, Pothoulakis C. Immunomodulatory properties of substance P: the gastrointestinal system as a model. Ann N Y Acad Sci 2006; 1088: 23-40.
51. Jessop DS, Renshaw D, Larsen PJ, Chowdrey HS, Harbuz MS. Substance P is involved in terminating the hypothalamo-pituitaryadrenal axis response to acute stress through centrally located neurokinin-1 receptors. Stress 2000; 3: 209-220.
52. Joos GF, De Swert KO, Pauwels RA. Airway inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists. Eur J Pharmacol 2001; 429: 239-250.
53. Mantyh PW. Neurobiology of substance P and the NK1 receptor. J Clin Psychiatry 2002; 63 Suppl 11: 6-10.
54. Lee HR, Ho WZ, Douglas SD. Substance Paugments tumor necrosis factor release in human monocyte-derived macrophages. Clin Diagn Lab Immunol 1994; 1: 419-423.
55. Bienenstock J, Tomioka M, Matsuda H, et al. The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions. Int Arch Allergy Appl Immunol 1987; 82: 238-243.
56. Bienenstock J, Tomioka M, Stead R, et al. Mast cell involvement in various inflammatory processes. Am Rev Respir Dis 1987; 135: S5-8.
57. Tomioka M, Goto T, Lee TD, Bienenstock J, Befus AD. Isolation and characterization of lung mast cells from rats with bleomycininduced pulmonary fibrosis. Immunology 1989; 66: 439-444.
58. van der Kleij HP, Ma D, Redegeld FA, Kraneveld AD, Nijkamp FP, Bienenstock J. Functional expression of neurokinin 1 receptors on mast cells induced by IL-4 and stem cell factor. J Immunol 2003; 171: 2074-2079.
59. Singh LK, Pang X, Alexacos N, Letourneau R, Theoharides TC. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders. Brain Behav Immun 1999; 13: 225-239.
60. Spanos C, Pang X, Ligris K, et al. Stress-induced bladder mast cell activation: implications for interstitial cystitis. J Urol 1997; 157: 669-672.
61. Joachim RA, Cifuentes LB, Sagach V, et al. Stress induces substance P in vagal sensory neurons innervating the mouse airways. Clin Exp Allergy 2006; 36: 1001-1010.
62. Joachim RA, Quarcoo D, Arck PC, Herz U, Renz H, Klapp BF. Stress enhances airway reactivity and airway inflammation in an animal model of allergic bronchial asthma. Psychosom Med 2003; 65: 811-815.
63. Joachim RA, Sagach V, Quarcoo D, Dinh QT, Arck PC, Klapp BF. Neurokinin-1 receptor mediates stress-exacerbated allergic airway inflammation and airway hyperresponsiveness in mice. Psychosom Med 2004; 66: 564-571.
64. Joachim RA, Sagach V, Quarcoo D, Dinh T, Arck PC, Klapp BF. Upregulation of tumor necrosis factor-alpha by stress and substance p in a murine model of allergic airway inflammation. Neuroimmunomodulation 2006; 13: 43-50.
65. Fest S, Zenclussen AC, Joachim R, Hagen E, Demuth HU, Hoffmann T. Stress and substance P but not the substance Pmetabolite SP5-11 trigger murine abortion by augmenting TNFalpha levels at the feto-maternal interface. Scand J Immunol 2006; 63: 42-49.
66. Peters EM, Kuhlmei A, Tobin DJ, Muller-Rover S, Klapp BF, Arck PC. Stress exposure modulates peptidergic innervation and degranulates mast cells in murine skin. Brain Behav Immun 2005; 19: 252-262.
67. Pavlovic S, Daniltchenko M, Tobin DJ, et al. Further exploring the brain-skin connection: stress worsens dermatitis via substance Pdependent neurogenic inflammation in mice. J Invest Dermatol 2008; 128: 434-446.
68. Abad C, Gomariz RP, Waschek JA. Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP. Curr Top Med Chem 2006; 6: 151-163.
69. Sherwood NM, Krueckl SL, McRory JE. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 2000; 21: 619-670.
70. Lygren I, Revhaug A, Burhol PG, Giercksky KE, Jenssen TG. Vasoactive intestinal polypeptide and somatostatin in leucocytes. Scand J Clin Lab Invest 1984; 44: 347-351.
71. Goetzl EJ, Sreedharan SP, Turck CW. Structurally distinctive vasoactive intestinal peptides from rat basophilic leukemia cells. J Biol Chem 1988; 263: 9083-9086.
72. Wershil BK, Turck CW, Sreedharan SP, et al. Variants of vasoactive intestinal peptide in mouse mast cells and rat basophilic leukemia cells. Cell Immunol 1993; 151: 369-378.
73. Delgado M, Leceta J, Sun W, Gomariz RP, Ganea D. VIP and PACAP induce shift to a Th2 response by upregulating B7.2 expression. Ann N Y Acad Sci 2000; 921: 68-78.
74. Foey AD, Field S, Ahmed S, et al. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis. Arthritis Res Ther 2003; 5: R317-328.
75. Ganea D, Delgado M. Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAP. Arch Immunol Ther Exp (Warsz) 2001; 49: 101-110.
76. Voice JK, Dorsam G, Chan RC, Grinninger C, Kong Y, Goetzl EJ. Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide. Regul Pept 2002; 109: 199-208.
77. Chorny A, Gonzalez-Rey E, Fernandez-Martin A, Ganea D, Delgado M. Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response. Blood 2006; 107: 3787-3794.
78. Delgado M, Gonzalez-Rey E, Ganea D. Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis. Ann N Y Acad Sci 2006; 1070: 233-238.
79. Delgado M, Reduta A, Sharma V, Ganea D. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells. J Leukoc Biol 2004; 75: 1122-30.
80. Gomariz R, Leceta J, Martinez C, Abad C, Ganea D, Delgado M. Anti-inflammatory actions of VIP/PACAP. Role in endotoxemia. Ann N Y Acad Sci 2000; 921: 284-8.
81. Weng Y, Sun J, Wu Q, Pan J. Regulatory effects of vasoactive intestinal peptide on the migration of mature dendritic cells. J Neuroimmunol 2007; 182: 48-54.
82. Chorny A, Gonzalez-Rey E, Delgado M. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation. Ann N Y Acad Sci 2006; 1088: 187-94.
83. Delgado M, Chorny A, Gonzalez-Rey E, Ganea D. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo. J Leukoc Biol 2005; 78: 1327-38.
84. Huang MC, Miller AL, Wang W, Kong Y, Paul S, Goetzl EJ. Differential signaling of T cell generation of IL-4 by wild-type and short-deletion variant of type 2 G protein-coupled receptor for vasoactive intestinal peptide (VPAC2). J Immunol 2006; 176: 6640-6.
85. Voice JK, Dorsam G, Lee H, Kong Y, Goetzl EJ. Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor. FASEB J 2001; 15: 2489-96.
86. Goetzl EJ, Voice JK, Shen S, et al. Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide. Proc Natl Acad Sci USA 2001; 98: 13854-13859.
87. Yadav M, Rosenbaum J, Goetzl EJ. Cutting edge: vasoactive intestinal peptide (VIP) induces differentiation of Th17 cells with a distinctive cytokine profile. J Immunol 2008; 180: 2772-2776.
88. Peluso I, Fantini MC, Fina D, et al. IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J Immunol 2007; 178: 732-739.
89. Boirivant M, Fais S, Annibale B, Agostini D, Delle Fave G, Pallone F. Vasoactive intestinal polypeptide modulates the in vitro immunoglobulin A production by intestinal lamina propria lymphocytes. Gastroenterology 1994; 106: 576-582.
90. Ohkubo N, Miura S, Serizawa H, et al. In vivo effect of chronic administration of vasoactive intestinal peptide on gut-associated lymphoid tissues in rats. Regul Pept 1994; 50: 127-135.
91. Fujieda S, Waschek JA, Zhang K, Saxon A. Vasoactive intestinal peptide induces S(alpha)/S(mu) switch circular DNA in human B cells. J Clin Invest 1996; 98: 1527-1532.
92. Kimata H, Fujimoto M. Induction of IgA1 and IgA2 production in immature human fetal B cells and pre-B cells by vasoactive intestinal peptide. Blood 1995; 85: 2098-2104.
93. Wang Y, Mei Y, Bao S, Xu L. Vasoactive intestinal polypeptide enhances oral tolerance by regulating both cellular and humoral immune responses. Clin Exp Immunol 2007; 148: 178-187.
94. Szema AM, Hamidi SA, Lyubsky S, et al. Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP. Am J Physiol Lung Cell Mol Physiol 2006; 291: L880-886.
95. Groneberg DA, Springer J, Fischer A. Vasoactive intestinal polypeptide as mediator of asthma. Pulm Pharmacol Ther 2001; 14: 391-401.
96. Cardell LO, Uddman R, Edvinsson L. Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma. Eur Respir J 1994; 7: 2169-2173.
97. Ollerenshaw S, Jarvis D, Woolcock A, Sullivan C, Scheibner T. Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N Engl J Med 1989; 320: 1244-1248.
98. Lilly CM, Bai TR, Shore SA, Hall AE, Drazen JM. Neuropeptide content of lungs from asthmatic and nonasthmatic patients. Am J Respir Crit Care Med 1995; 151: 548-553.
99. Chanez P, Springall D, Vignola AM, et al. Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway diseases. Am J Respir Crit Care Med 1998; 158: 985-990.
100. Wang F, Millet I, Bottomly K, Vignery A. Calcitonin gene-related peptide inhibits interleukin 2 production by murine T lymphocytes. J Biol Chem 1992; 267: 21052-21057.
101. Fox FE, Kubin M, Cassin M, et al. Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects on B7, interleukin 10, and interleukin 12. J Invest Dermatol 1997; 108: 43-48.
102. Umeda Y, Takamiya M, Yoshizaki H, Arisawa M. Inhibition of mitogen-stimulated T lymphocyte proliferation by calcitonin generelated peptide. Biochem Biophys Res Commun 1988; 154: 227-235.
103. Fernandez S, Knopf MA, McGillis JP. Calcitonin-gene related peptide (CGRP) inhibits interleukin-7-induced pre-B cell colony formation. J Leukoc Biol 2000; 67: 669-676.
104. Asahina A, Hosoi J, Beissert S, Stratigos A, Granstein RD. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. J Immunol 1995; 154: 3056-3061.
105. Hosoi J, Murphy GF, Egan CL, et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993; 363: 159-163.
106. Rychter JW, Van Nassauw L, Timmermans JP, Akkermans LM, Westerink RH, Kroese AB. CGRP1 receptor activation induces piecemeal release of protease-1 from mouse bone marrow-derived mucosal mast cells. Neurogastroenterol Motil 2011; 23: e57-68.
107. Kay AB, Ali FR, Heaney LG, et al. Airway expression of calcitonin gene-related peptide in T-cell peptide-induced late asthmatic reactions in atopics. Allergy 2007; 62: 495-503.
108. Antunez C, Torres MJ, Lopez S, et al. Calcitonin gene-related peptide modulates interleukin-13 in circulating cutaneous lymphocyte- associated antigen-positive T cells in patients with atopic dermatitis. Br J Dermatol 2009; 161: 547-553.
109. Forsythe P, McGarvey LP, Heaney LG, MacMahon J, Ennis M. Sensory neuropeptides induce histamine release from bronchoalveolar lavage cells in both nonasthmatic coughers and cough variant asthmatics. Clin Exp Allergy 2000; 30: 225-232.
110. Braun A, Wiebe P, Pfeufer A, Gessner R, Renz H. Differential modulation of human immunoglobulin isotype production by the neuropeptides substance P, NKA and NKB. J Neuroimmunol 1999; 97: 43-50.
111. Sun J, Ramnath RD, Tamizhselvi R, Bhatia M. Neurokinin A engages neurokinin-1 receptor to induce NF-kappaB-dependent gene expression in murine macrophages: implications of ERK1/2 and PI 3-kinase/Akt pathways. Am J Physiol Cell Physiol 2008; 295: C679-91.
112. Joos GF, Pauwels RA. The in vivo effect of tachykinins on airway mast cells of the rat. Am Rev Respir Dis 1993; 148: 922-926.
113. Kraneveld AD, Nijkamp FP. Tachykinins and neuro-immune interactions in asthma. Int Immunopharmacol 2001; 1: 1629-1650.
114. Hood VC, Cruwys SC, Urban L, Kidd BL. Differential role of neurokinin receptors in human lymphocyte and monocyte chemotaxis. Regul Pept 2000; 96: 17-21.
115. Scholzen TE, Steinhoff M, Sindrilaru A, et al. Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage. FASEB J 2004; 18: 1007-1009.
116. Katsanos GS, Anogianaki A, Castellani ML, et al. Biology of neurotensin: revisited study. Int J Immunopathol Pharmacol 2008; 21: 255-9.
117. Margolis KG, Gershon MD. Neuropeptides and inflammatory bowel disease. Curr Opin Gastroenterol 2009; 25: 503-511.
118. St-Gelais F, Jomphe C, Trudeau LE. The role of neurotensin in central nervous system pathophysiology: what is the evidence? J Psychiatry Neurosci 2006; 31: 229-245.
119. Goldman R, Bar-Shavit Z, Romeo D. Neurotensin modulates human neutrophil locomotion and phagocytic capability. FEBS Lett 1983; 159: 63-67.
120. Robbins RA, Nelson KJ, Gossman GL, Rubinstein I. Neurotensin stimulates neutrophil adherence to bronchial epithelial cells in vitro. Life Sci 1995; 56: 1353-1359.
121. Carraway R, Cochrane DE, Lansman JB, Leeman SE, Paterson BM, Welch HJ. Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels. J Physiol 1982; 323: 403-414.
122. Cochrane DE, Carraway RE, Harrington K, Laudano M, Rawlings S, Feldberg RS. HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1. Inflamm Res 2011
123. Frieling T, Cooke HJ, Wood JD. Serotonin receptors on submucous neurons in guinea pig colon. Am J Physiol 1991; 261: G1017-23.
124. Frieling T, Cooke HJ, Wood JD. Histamine receptors on submucous neurons in guinea pig colon. Am J Physiol 1993; 264: G74-80.
125. van Houwelingen AH, Kool M, de Jager SCA, et al. Mast Cell- Derived TNF-[alpha] Primes Sensory Nerve Endings in a Pulmonary Hypersensitivity Reaction. J Immunol 2002; 168: 5297-5302.
126. Leon A, Buriani A, Dal Toso R, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994; 91: 3739-3743.
127. Kakurai M, Monteforte R, Suto H, Tsai M, Nakae S, Galli SJ. Mast cell-derived tumor necrosis factor can promote nerve fiber elongation in the skin during contact hypersensitivity in mice. Am J Pathol 2006; 169: 1713-1721.
128. Arnett HA, Wang Y, Matsushima GK, Suzuki K, Ting JP. Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J Neurosci 2003; 23: 9824-9832.
129. Andersson RG, Grundstrom N. Innervation of airway smooth muscle. Efferent mechanisms. Pharmacol Ther 1987; 32: 107-130.
130. Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, Bienenstock J. Intestinal mucosal mast cells in normal and nematodeinfected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA 1987; 84: 2975-2979.
131. Porzionato A, Macchi V, Parenti A, De Caro R. The distribution of mast cells in the human area postrema. J Anat 2004; 204: 141-147.
132. Theoharides TC. Mast cells: the immune gate to the brain. Life Sci 1990; 46: 607-17.
133. Undem BJ, Riccio MM, Weinreich D, Ellis JL, Myers AC. Neurophysiology of mast cell-nerve interactions in the airways. Int Arch Allergy Immunol 1995; 107: 199-201.
134. Barnes PJ. Airway inflammation and autonomic control. Eur J Respir Dis Suppl 1986; 147: 80-87.
135. Steinhoff M, Vergnolle N, Young SH, et al. Agonists of proteinaseactivated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000; 6: 151-158.
136. Ibrahim MZ. The mast cells of the mammalian central nervous system. IX. Development of the mast cells in the brain of the young rat. Acta Anat (Basel) 1985; 124: 149-158.
137. Lambracht-Hall M, Dimitriadou V, Theoharides TC. Migration of mast cells in the developing rat brain. Brain Res Dev Brain Res 1990; 56: 151-159.
138. Michaloudi HC, Papadopoulos GC. Mast cells in the sheep, hedgehog and rat forebrain. J Anat 1999; 195: 577-586.
139. Nautiyal KM, Ribeiro AC, Pfaff DW, Silver R. Brain mast cells link the immune system to anxiety-like behavior. Proc Natl Acad Sci USA 2008; 105: 18053-7.
140. Esposito P, Gheorghe D, Kandere K, et al. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res 2001; 888: 117-127.
141. Matsumoto I, Inoue Y, Shimada T, Aikawa T. Brain mast cells act as an immune gate to the hypothalamic-pituitary-adrenal axis in dogs. J Exp Med 2001; 194: 71-78.
142. Esposito P, Chandler N, Kandere K, et al. Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther 2002; 303: 1061-1066.
143. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 1998; 94: 557-572.
144. Barnes PJ. Molecular mechanisms and cellular effects of glucocorticosteroids. Immunol Allergy Clin North Am 2005; 25: 451-468.
145. Barnes PJ. Corticosteroid effects on cell signalling. Eur Respir J 2006; 27: 413-426.
146. Biederer T, Sara Y, Mozhayeva M, et al. SynCAM, a synaptic adhesion molecule that drives synapse assembly. Science 2002; 297: 1525-1531.
147. Adcock IM, Caramori G, Ito K. New insights into the molecular mechanisms of corticosteroids actions. Curr Drug Targets 2006; 7: 649-660.
148. Furuno T, Ito A, Koma Y, et al. The spermatogenic Ig superfamily/ synaptic cell adhesion molecule mast-cell adhesion molecule promotes interaction with nerves. J Immunol 2005; 174: 6934-6942.
149. Biederer T. Bioinformatic characterization of the SynCAM family of immunoglobulin-like domain-containing adhesion molecules. Genomics 2006; 87: 139-150.
150. Ito A, Nishikawa Y, Ohnuma K, et al. SgIGSF is a novel biliaryepithelial cell adhesion molecule mediating duct/ductule development. Hepatology 2007; 45: 684-694.
151. Koma Y, Ito A, Wakayama T, et al. Cloning of a soluble isoform of the SgIGSF adhesion molecule that binds the extracellular domain of the membrane-bound isoform. Oncogene 2004; 23: 5687-5692.
152. Ito A, Oonuma J. Direct interaction between nerves and mast cells mediated by the SgIGSF/SynCAM adhesion molecule. J Pharmacol Sci 2006; 102: 1-5.
153. Hagiyama M, Furuno T, Hosokawa Y, et al. Enhanced nerve-mast cell interaction by a neuronal short isoform of cell adhesion molecule- 1. J Immunol 2011; 186: 5983-5992.
154. Tegoshi T, Nishida M, Arizono N. Expression and role of Ecadherin and CD103beta7 (alphaEbeta7 integrin) on cultured mucosal- type mast cells. APMIS 2005; 113: 91-98.
155. Suzuki A, Suzuki R, Furuno T, Teshima R, Nakanishi M. Ncadherin plays a role in the synapse-like structures between mast cells and neurites. Biol Pharm Bull 2004; 27: 1891-1894.
156. Janiszewski J, Bienenstock J, Blennerhassett MG. Picomolar doses of substance P trigger electrical responses in mast cells without degranulation. Am J Physiol 1994; 267: C138-145.
157. Suzuki R, Furuno T, McKay DM, et al. Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J Immunol 1999; 163: 2410-2415.
158. Anzai R, Seki S, Ogasawara K, et al. Interleukin-12 induces cytotoxic NK1+ alpha beta T cells in the lungs of euthymic and athymic mice. Immunology 1996; 88: 82-89.
159. Azzolina A, Bongiovanni A, Lampiasi N. Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim Biophys Acta 2003; 1643: 75-83.
160. Okabe T, Hide M, Hiragun T, Morita E, Koro O, Yamamoto S. Bone marrow derived mast cell acquire responsiveness to substance P with Ca(2+) signals and release of leukotriene B(4) via mitogenactivated protein kinase. J Neuroimmunol 2006; 181: 1-12.
161. Ogasawara T, Murakami M, Suzuki-Nishimura T, Uchida MK, Kudo I. Mouse bone marrow-derived mast cells undergo exocytosis, prostanoid generation, and cytokine expression in response to G protein-activating polybasic compounds after coculture with fibroblasts in the presence of c-kit ligand. J Immunol 1997; 158: 393-404.
162. Karimi K, Redegeld FA, Blom R, Nijkamp FP. Stem cell factor and interleukin-4 increase responsiveness of mast cells to substance P. Exp Hematol 2000; 28: 626-634.
163. Mori N, Suzuki R, Furuno T, et al. Nerve-mast cell (RBL) interaction: RBL membrane ruffling occurs at the contact site with an activated neurite. Am J Physiol Cell Physiol 2002; 283: C1738-1744.
164. Blennerhassett MG, Bienenstock J. Sympathetic nerve contact causes maturation of mast cells in vitro. J Neurobiol 1998; 35: 173-182.
165. Suzuki A, Suzuki R, Furuno T, Teshima R, Nakanishi M. Calcium response and FcepsilonRI expression in bone marrow-derived mast cells co-cultured with SCG neurites. Biol Pharm Bull 2005; 28: 1963-1965.
166. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-462.
167. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 2006; 131: 1122-1130.
168. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-388.
169. Huston JM, Ochani M, Rosas-Ballina M, et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 2006; 203: 1623-1628.
170. Huston JM, Rosas-Ballina M, Xue X, et al. Cholinergic neural signals to the spleen down-regulate leukocyte trafficking via CD11b. J Immunol 2009; 183: 552-559.
171. Rosas-Ballina M, Ochani M, Parrish WR, et al. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci USA 2008; 105: 11008-11013.
172. Bellinger DL, Lorton D, Hamill RW, Felten SY, Felten DL. Acetylcholinesterase staining and choline acetyltransferase activity in the young adult rat spleen: lack of evidence for cholinergic innervation. Brain Behav Immun 1993; 7: 191-204.
173. Buijs RM, van der Vliet J, Garidou ML, Huitinga I, Escobar C. Spleen vagal denervation inhibits the production of antibodies to circulating antigens. PLoS ONE 2008; 3: e3152.
174. Chen XH, Itoh M, Sun W, Miki T, Takeuchi Y. Localization of sympathetic and parasympathetic neurons innervating pancreas and spleen in the cat. J Auton Nerv Syst 1996; 59: 12-16.
175. van Westerloo DJ, Giebelen IA, Florquin S, et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 2006; 130: 1822-1830.
176. Pavlov VA, Ochani M, Yang LH, et al. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med 2007; 35: 1139-1144.
177. O'Mahony C, van der Kleij H, Bienenstock J, Shanahan F, O'Mahony L. Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer. Am J Physiol Regul Integr Comp Physiol 2009; 297: R1118-1126.
178. Karimi K, Bienenstock J, Wang L, Forsythe P. The vagus nerve modulates CD4+ T cell activity. Brain Behav Immun 2010; 24: 316-323.
179. Matsunaga K, Klein TW, Friedman H, Yamamoto Y. Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol 2001; 167: 6518-24.
180. Orr-Urtreger A, Kedmi M, Rosner S, Karmeli F, Rachmilewitz D. Increased severity of experimental colitis in alpha 5 nicotinic acetylcholine receptor subunit-deficient mice. Neuroreport 2005; 16: 1123-1127.
181. Skok M, Grailhe R, Agenes F, Changeux JP. The role of nicotinic acetylcholine receptors in lymphocyte development. J Neuroimmunol 2006; 171: 86-98.
182. Nouri-Shirazi M, Guinet E. Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology 2003; 109: 365-373.
183. Guinet E, Yoshida K, Nouri-Shirazi M. Nicotinic environment affects the differentiation and functional maturation of monocytes derived dendritic cells (DCs). Immunol Lett 2004; 95: 45-55.
184. Nouri-Shirazi M, Tinajero R, Guinet E. Nicotine alters the biological activities of developing mouse bone marrow-derived dendritic cells (DCs). Immunol Lett 2007; 109: 155-164.
185. Aicher A, Heeschen C, Mohaupt M, Cooke JP, Zeiher AM, Dimmeler S. Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions. Circulation 2003; 107: 604-611.
186. Gao FG, Wan da F, Gu JR. Ex vivo nicotine stimulation augments the efficacy of therapeutic bone marrow-derived dendritic cell vaccination. Clin Cancer Res 2007; 13: 3706-3712.
187. Williams RM, Berthoud HR, Stead RH. Vagal afferent nerve fibres contact mast cells in rat small intestinal mucosa. Neuroimmunomodulation 1997; 4: 266-270.
188. Gottwald T, Lhotak S, Stead RH. Effect of truncal vagotomy and capsaicin on mast cells and IgA-positive plasma cells in rat jejunal mucosa. Neurogastroenterol Motil 1997; 9: 25-32.
189. Gottwald TP, Hewlett BR, Lhotak S, Stead RH. Electrical stimulation of the vagus nerve modulates the histamine content of mast cells in the rat jejunal mucosa. Neuroreport 1995; 7: 313-317.
190. Kageyama-Yahara N, Suehiro Y, Yamamoto T, Kadowaki M. IgEinduced degranulation of mucosal mast cells is negatively regulated via nicotinic acetylcholine receptors. Biochem Biophys Res Commun 2008; 377: 321-325.
191. Mishra NC, Rir-sima-ah J, Boyd RT, et al. Nicotine inhibits Fc epsilon RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha 7/alpha 9/alpha 10-nicotinic receptors. J Immunol 2010; 185: 588-596.
192. Kindt F, Wiegand S, Niemeier V, et al. Reduced expression of nicotinic alpha subunits 3, 7, 9 and 10 in lesional and nonlesional atopic dermatitis skin but enhanced expression of alpha subunits 3 and 5 in mast cells. Br J Dermatol 2008; 159: 847-857.
193. Halaris A. Comorbidity between depression and cardiovascular disease. Int Angiol 2009; 28: 92-99.
194. Gazelle H, Druhen MJ. Anxious solitude and peer exclusion predict social helplessness, upset affect, and vagal regulation in response to behavioral rejection by a friend. Dev Psychol 2009; 45: 1077-1096.
195. Miu AC, Heilman RM, Miclea M. Reduced heart rate variability and vagal tone in anxiety: trait versus state, and the effects of autogenic training. Auton Neurosci 2009; 145: 99-103.
196. Andoh T, Kuraishi Y. Direct action of immunoglobulin G on primary sensory neurons through Fc gamma receptor I. FASEB J 2004; 18: 182-184.
197. Andoh T, Kuraishi Y. Expression of Fc epsilon receptor I on primary sensory neurons in mice. Neuroreport 2004; 15: 2029-2031.
198. Rijnierse A, Kroese AB, Redegeld FA, et al. Immunoglobulin-free light chains mediate antigen-specific responses of murine dorsal root ganglion neurons. J Neuroimmunol 2009; 208: 80-6.
199. Liang H, Xu L, Zhou C, Zhang Y, Xu M, Zhang C. Vagal activities are involved in antigen-specific immune inflammation in the intestine. J Gastroenterol Hepatol 2011; 26: 1065-1071.
200. Pacheco-Lopez G, Niemi MB, Engler H, Schedlowski M. Neuro- Immune Associative Learning 2007; Neural Plasticity and Memory: From Genes to Brain Imaging
201. Ader R, Cohen N. Behaviorally conditioned immunosuppression. Psychosom Med 1975; 37: 333-340.
202. Exton MS, Schult M, Donath S, et al. Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation. Am J Physiol 1999; 276: R1710-1717.
203. Ader R, Mercurio MG, Walton J, et al. Conditioned pharmacotherapeutic effects: a preliminary study. Psychosom Med 2010; 72: 192-197.
204. Dantzer R, Konsman JP, Bluthe RM, Kelley KW. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton Neurosci 2000; 85: 60-65.
205. Goehler LE, Lyte M, Gaykema RP. Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology. Brain Behav Immun 2007; 21: 721-726.
206. Maier SF, Goehler LE, Fleshner M, Watkins LR. The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci 1998; 840: 289-300.
207. Gaykema RP, Goehler LE, Hansen MK, Maier SF, Watkins LR. Subdiaphragmatic vagotomy blocks interleukin-1beta-induced fever but does not reduce IL-1beta levels in the circulation. Auton Neurosci 2000; 85: 72-77.
208. Konsman JP, Luheshi GN, Bluthe RM, Dantzer R. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur J Neurosci 2000; 12: 4434-4446.
209. Luheshi GN, Bluthe RM, Rushforth D, et al. Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats. Auton Neurosci 2000; 85: 127-132.
210. Pacheco-Lopez G, Niemi MB, Kou W, Harting M, Fandrey J, Schedlowski M. Neural substrates for behaviorally conditioned immunosuppression in the rat. J Neurosci 2005; 25: 2330-2337.
211. Exton MS, Gierse C, Meier B, et al. Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and beta-adrenoceptors. J Neuroimmunol 2002; 131: 21-30.
212. Exton MS, von Horsten S, Schult M, et al. Behaviorally conditioned immunosuppression using cyclosporine A: central nervous system reduces IL-2 production via splenic innervation. J Neuroimmunol 1998; 88: 182-191.
213. Exton MS, Elfers A, Jeong WY, Bull DF, Westermann J, Schedlowski M. Conditioned suppression of contact sensitivity is independent of sympathetic splenic innervation. Am J Physiol Regul Integr Comp Physiol 2000; 279: R1310-1315.
214. Irie M, Nagata S, Endo Y. Fasting stress exacerbates classical conditioned histamine release in guinea pigs. Life Sci 2002; 72: 689-698.
215. Irie M, Nagata S, Endo Y. Diazepam attenuates conditioned histamine release in guinea pigs. Int J Psychophysiol 2004; 51: 231-238.
216. MacQueen G, Marshall J, Perdue M, Siegel S, Bienenstock J. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 1989; 243: 83-85.
217. Goebel MU, Meykadeh N, Kou W, Schedlowski M, Hengge UR. Behavioral conditioning of antihistamine effects in patients with allergic rhinitis. Psychother Psychosom 2008; 77: 227-234.
218. Rosenkranz MA, Busse WW, Johnstone T, et al. Neural circuitry underlying the interaction between emotion and asthma symptom exacerbation. Proc Natl Acad Sci USA 2005; 102: 13319-13324.
219. Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 2002; 3: 655-666.
220. Craig AD. How do you feel--now? The anterior insula and human awareness. Nat Rev Neurosci 2009; 10: 59-70.
221. Ohira H, Fukuyama S, Kimura K, et al. Regulation of natural killer cell redistribution by prefrontal cortex during stochastic learning. Neuroimage 2009; 47: 897-907.
222. O'Connor MF, Irwin MR, Wellisch DK. When grief heats up: proinflammatory cytokines predict regional brain activation. Neuroimage 2009; 47: 891-896.
223. Basso AS, Pinto FA, Russo M, Britto LR, de Sa-Rocha LC, Palermo Neto J. Neural correlates of IgE-mediated food allergy. J Neuroimmunol 2003; 140: 69-77.
224. Basso AS, Costa-Pinto FA, Britto LR, de Sa-Rocha LC, Palermo-Neto J. Neural pathways involved in food allergy signaling in the mouse brain: role of capsaicin-sensitive afferents. Brain Res 2004; 1009: 181-188.
225. Costa-Pinto FA, Basso AS, Britto LR, Malucelli BE, Russo M. Avoidance behavior and neural correlates of allergen exposure in a murine model of asthma. Brain Behav Immun 2005; 19: 52-60.
226. Costa-Pinto FA, Basso AS, Russo M. Role of mast cell degranulation in the neural correlates of the immediate allergic reaction in a murine model of asthma. Brain Behav Immun 2007; 21: 783-790.
227. Basso AS, de Sa-Rocha LC, Palermo-Neto J. Immune-induced flavor aversion in mice: modification by neonatal capsaicin treatment. Neuroimmunomodulation 2001; 9: 88-94.
228. Zarzana EC, Basso AS, Costa-Pinto FA, Palermo-Neto J. Pharmacological manipulation of immune-induced food aversion in rats. Neuroimmunomodulation 2009; 16: 19-27.
229. Fox AJ. Modulation of cough and airway sensory fibres. Pulm Pharmacol 1996; 9: 335-342.
230. Razavi R, Chan Y, Afifiyan FN, et al. TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes. Cell 2006; 127: 1123-135.
231. Holz GGT, Kream RM, Spiegel A, Dunlap K. G proteins couple alpha-adrenergic and GABAb receptors to inhibition of peptide secretion from peripheral sensory neurons. J Neurosci 1989; 9: 657-666.
232. Theoharides TC, Zhang B, Kempuraj D, et al. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci USA 2010; 107: 4448-4453.